Combination therapies for treating cancer
Grant
US12576075B2
Kind: B2
Mar 17, 2026
Assignee
INSTITUTE FOR CANCER RESEARCH
Inventors
Petr Makhov, Vladimir Kolenko
Abstract
Pharmaceutical compositions comprising a tyrosine kinase inhibitor and a farnesyltransferase inhibitor, or pharmaceutically acceptable salts thereof, and a pharmaceutically acceptable carrier, as well as methods for preventing or treating cancer by administering the same are disclosed herein.
CPC Classifications
A61K 31/4545
A61K 9/0053
A61K 31/404
A61K 31/4709
A61K 45/06
A61K 9/0014
A61K 9/0024
A61K 9/0095
A61K 9/06
A61K 9/08
A61K 9/10
A61K 9/107
A61K 9/12
A61K 9/122
A61K 9/2004
A61K 9/4841
A61K 9/7023
A61K 9/0019
A61K 31/44
A61K 31/4439
A61K 31/517
A61P 35/04
Filing Date
2019-10-30
Application No.
17288982
Claims
5